TWST Twist Bioscience Corporation

NASDAQ
$142.58

Twist Bioscience Corporation (TWST) is confirmed to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.44 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +74.7% since its last earnings release on August 3, 2026.

Twist Bioscience Missed Consensus Estimates, Sees Fourth Quarter Above Estimates
Monday, August 3, 2026 · 7:15 AM ET
Earnings Date
4th Quarter, Sep 2026
Nov 12
Thursday · 7:15 AM ET
Earnings Whisper
($0.40)
vs ($0.44) +$0.04
Rev est $123.4M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $150.48

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.

Sector

Healthcare

Industry

Biotechnology

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.